Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 3, 1996, Pages 967-975

  Belman, Michael J ^a,b   Botnick, Warren C ^a   Shin, John W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

AIRFLOW; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DYSPNEA; EXERCISE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INSPIRATORY CAPACITY; LUNG FUNCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SMOKING;

EID: 0030012048     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.3.8630581     Document Type: Article

References (28)

1. Pratter, M. R., and R. S. Irwin. 1988. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease. Arch. Intern. Med. 148:1909-1910.
2. Ramsdell, J. W., and G. M. Tisi. 1979. Determination of bronchodilation in the clinical pulmonary function laboratory. Role of changes in static lung volumes. Chest 76:622-628.
3. Chrystyn, H., and M. D. Peake. 1988. Dose response relation to oral theophylline in severe chronic obstructive airways disease. B.M.J. 297:1506-1510.
4. Peake, M. D., S. Freestone, and P. Howard. 1981. Changes in trapped gas volume and other tests of air flow obstruction in exacerbations of chronic obstructive airways disease and asthma. Eur. J. Respir. Dis. 62:170-171.
5. Jenne, J. W., J. R. Siever, W. S. Druz, and J. T. Sharp. 1984. The effect of maintenance theophylline on lung work in severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 130:600-605.
6. American Thoracic Society. 1987. Standardization of spirometry - 1987 update. Am. Rev. Respir. Dis. 136:1285-1298.
7. Guyatt, G. H., M. Townsend, S. Nogradi, S. O. Pugsley, J. L. Keller, and M. T. Newhouse. 1988. Acute response to bronchodilator: an imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch. Intern. Med. 148:1949-1952.
8. Lougheed, M. D., M. Lam, L. Forkert, K. A. Webb, and D. E. O'Donnell. 1993. Breathlessness during acute bronchoconstriction in asthma. Am. Rev. Respir. Dis. 148:1452-1459.
9. O'Donnell, D. E., and K. A. Webb. 1993. Exertional breathlessness in patients with chronic airflow limitation. Am. Rev. Respir. Dis. 148: 1351-1357.
10. Johnson, B. D., W. G. Reddan, D. F. Pegelow, K. C. Seow, and J. A. Dempsey. 1991. Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am. Rev. Respir. Dis. 143:960-967.
11. Johnson, B. D., W. G. Reddan, K. C. Seow, and J. A. Dempsey. 1991. Mechanical constraints on exercise hyperpnea in a fit aging population. Am. Rev. Respir. Dis. 143:968-977.
12. LeBlanc, P., E. Summers, M. D. Inman, N. L. Jones, E. J. Campbell, and K. J. Killian. 1988. Inspiratory muscles during exercise: a problem of supply and demand. J Appl. Physiol. 64:2482-2489.
13. Babb, T. G., and J. R. Rodarte. 1991. Effect of mild-to-moderate airflow limitation on exercise capacity. J. Appl. Physiol. 70:223-230.
14. Dodd, D. S., and L. Engel. 1984. Chest wall mechanics during exercise in patients with severe chronic airflow obstruction. Am. Rev. Respir. Dis. 129:33-38.
15. Younes, M. 1991. Determinants of thoracic excursions during exercise. In B. J. Whipp and K. Wasserman, editors. Lung Biology in Health and Disease, Vol. 52. Exercise Pulmonary Physiology and Pathophysiology. Marcel Dekker, New York. 1-65.
16. O'Donnell, D. E. 1994. Breathlessness in patients with chronic airflow limitation: mechanisms and management. Chest 106:904-912.
17. LeBlanc, P., D. M. Bowie, E. Summers, N. L. Jones, and K. J. Killian. 1986. Breathlessness and exercise in patients with cardiorespiratory disease. Am. Rev. Respir. Dis. 133:21-25.
18. Potter, W. A.,S. Olafsson, and R. E. Hyatt. 1971. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J. Clin. Invest. 50:910-919.
19. Sharp, J. T., W. S. Drutz, and T. Moisan. 1980. Postural relief of dyspnea in severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 122:201-211.
20. Borg, G. 1982. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 5:377-381.
21. Stubbing, D. G., L. D. Pengelly, J. L. C. Morse, and N. L. Jones. 1980. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J. Appl. Physiol. 49:511-515.
22. Johnson, B. D., and J. A. Dempsey. 1992. Mechanical constraints on exercise hyperpnea in endurance athletes. J. Appl. Physiol. 73:874-886.
23. Lanigan, C., T. Q. Howes, G. Borzone, L. G. Vianna, and J. Moxham. 1993. The effects of beta 2-agonists and caffeine on respiratory and limb muscle performance. Eur. Respir. J. 6:1192-1196.
24. Murciano, D., M. H. Auclair, R. Pariente, and M. Aubier. 1984. A randomized controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N. Engl. J. Med. 320:1521-1525.
25. Moxham, J. 1988. Aminophylline and the respiratory muscles. An alternative view. Clin. Chest Med. 9:325-336.
26. O'Donnell, D. E., R. Sanii, G. Giesbrecht, and M. Younes. 1988. Effect of continuous positive airway pressure on respiratory sensation in patients with chronic obstructive pulmonary disease during submaximal exercise. Am. Rev. Respir. Dis. 138:1185-1191.
27. Petrof, B. J., E. Calderini, and S. B. Gottfried. 1990. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J. Appl. Physiol. 69:179-188.
28. Guyatt, G. H., J. L. Keller, R. Jaeschke, D. Rosenbloom, J. D. Adachi, and M. T. Newhouse. 1990. The n-of-1 randomized controlled trial: clinical usefulness: our three year experience. Ann. Intern. Med. 112: 293-299.